The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #8 is a biotech by the name of Kura Oncology (KURA). The reason why I want to go over this biotech again ...
The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #9 is a biotech by the name of Immunic (IMUX). The reason why I believe that it is important to go over ...
We recently compiled a list of the 20 Best Biotech Stocks Under $20 to Buy Now. Black Diamond Therapeutics, Inc. is one of ...
Opinion
AI's promise, biotech's peril: How unequal access to computing power threatens medical breakthroughs
One way leads to a future in which AI-driven breakthroughs remain the exclusive domain of pharmaceutical giants with billion-dollar budgets. The other, to a landscape where breakthroughs regularly ...
After 15 years at Genentech, where his work has spanned small molecules, antibody drug conjugates, and now cell and gene therapies – Don has become one of the company’s most vocal champions for the ...
For biotech companies the past two years have been challenging. Biotech investments have not reached the record levels of 2020 and 2021 and an anticipated stock recovery in 2024 failed to materialise.
Atelerix, a biotech company working on cell preservation and biological transport with its hydrogel encapsulation technology, entered a partnership with Cherry Biotech, a French company specializing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results